Who invested in Orbus Therapeutics?
Orbus Therapeutics's investors include Adams Street Partners, Longitude Capital, H.I.G. BioVentures and Ernest Mario.
United States · Series A startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$33Mraised across 1 round since 2015, from 1 source
From a historical funding recordSEC filing: $18M sold, first sale Aug 2015
Orbus Therapeutics's investors include Adams Street Partners, Longitude Capital, H.I.G. BioVentures and Ernest Mario.
Orbus Therapeutics has raised $33M across 1 round since 2015.
Orbus Therapeutics's most recent round was a Series A of $33M in Aug 2015.
Its most recent round, $33M in Aug 2015, is also its largest on record.
Orbus Therapeutics's first round on record, in Aug 2015, was backed by Adams Street Partners, Longitude Capital and H.I.G. BioVentures and 1 others.
Orbus Therapeutics's latest named round is a Series A, in Aug 2015.
Orbus Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.